Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The company has entered into a three-year Deferred Prosecution Agreement
Need to harmonize traditional and modern medicine to combat alarming health problems
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Nous-209 has been developed using the Nouscom's viral vector platform
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Subscribe To Our Newsletter & Stay Updated